Clinical Trial Update: Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas [Phase 2]

View source ↗

Summary

Phase 2 trial of mFOLFOX6 plus trastuzumab and avelumab in gastric and esophageal adenocarcinoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma
• Gastric Adenocarcinoma

Drugs mentioned

• Avelumab (avelumab)
• MFOLFOX6
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Ashwin Somasundaram | Conditions: Gastric Adenocarcinoma, Esophageal Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2023-12-19